JAK2 V617F in myeloid disorders: What do we know now, and where are we headed?
Maria E. Nelson & David P. Steensma.
Leukemia and Lymphoma 2006;47(2):177 – 194.
The publishers would like to apologise for an error that occurred in colouration of in the above-mentioned article. The corrected figure is shown below.